Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods - Quiz - MDSpire

Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods

  • By

  • Adrien Saucier

  • Bouchra Nasri

  • Britt McKinnon

  • Mabel Carabali

  • Laura Pierce

  • Katia Charland

  • Kate Zinszer

  • August 12, 2024

  • 0 min

Share

Original Source(s)

Generalizability of anti–SARS-CoV-2 seroprevalence estimates to the Montréal pediatric population: a comparison between 2 weighting methods

  • by Adrien Saucier, Bouchra Nasri, Britt McKinnon, Mabel Carabali, Laura Pierce, Katia Charland, Kate Zinszer

  • August 12, 2024

Related Content

FDA OKs Linaclotide in Young Children

Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Predictors of early response to GnRH and gonadotropin therapy in pediatric patients with suspected dual congenital hypogonadotropic hypogonadism: a retrospective single-center study